Target intelligence / Profile preview

39S ribosomal protein L23, mitochondrial (MRPL23)

Target
MRPL23
Molecular classification
Ribosomal protein, Structural constituent of mitochondrial large ribosomal subunit, Other (not a receptor, enzyme, transporter, transcription factor, or ion channel)
01

Overview

MRPL23 (39S ribosomal protein L23, mitochondrial) is a nuclear-encoded structural protein that forms part of the large 39S subunit of the mitochondrial ribosome (mitoribosome), which mediates mitochondrial protein synthesis. Mitochondrial ribosomes are distinct from cytosolic and bacterial ribosomes in their high protein:RNA ratio (~75%), lack of 5S rRNA, and substantial sequence variability between species. MRPL23 is crucial for the correct assembly and operation of the mitoribosome but is not a direct target for drugs or therapeutic intervention. Rare disease associations have been noted, but its principal biological role is structural and translational within mitochondria

Other names
MRPL23L23MRPRPL23RPL23LL23mtMRP-L23mitochondrial ribosomal protein L2339S ribosomal protein L23, mitochondriallarge ribosomal subunit protein uL23mRibosomal protein L23-likeL23 mitochondrial-related protein
02

Biological functions

Structural constituent of ribosomeMitochondrial translationProtein synthesis within mitochondrionRNA bindingProtein binding
03

Disease associations

Very limited direct association. Some studies link MRPL23 to Wilms Tumor 2 and Beckwith-Wiedemann Syndrome, but it is not considered a classical disease gene or drug target

Beyond the preview

Go deeper on 39S ribosomal protein L23, mitochondrial (MRPL23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 39S ribosomal protein L23, mitochondrial (MRPL23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call